Barinthus Share Price

Barinthus Share Price

NASDAQ: BRNS | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Barinthus Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Barinthus Share Price Chart

$0.00$0.00
L
Show Current Price
H

Barinthus Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.02
Revenue (TTM)
$0.00
Return On Equity (TTM)
-73.18%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
27.39%

Barinthus Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.57-$11.09-$5.53-$10.58
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A23.88%50.14%-91.32%

Barinthus Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.80$14.97$0.00
Net Profit-$73.35-$61.07-$66.43
Net Profit Margin-9168.75%-407.95%N/A
Income ChangeN/A16.74%-8.78%

Barinthus Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets20.3834.5957.6
Current Assets77.79125.74156.91
Total Assets98.17160.33214.51
Non Current Liabilities13.8614.5414.91
Current Liabilities10.0215.6612.6
Total Liabilities23.8830.1927.51
Shareholders' Equity74.29130.14187.0

Barinthus Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-47.98-28.94-50.93
Investing0.42-0.89-5.41
Financing0.02.161.87

About Barinthus

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Barinthus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Barinthus Share Price FAQs